2012/01/05 13:00 - Asian Activities Report for January 5, 2012 includes: China Titans Energy Technology Group (HKG:2188) says that its subsidiary Zhuhai Titans Automatic Technology has received an Outstanding Contribution Enterprise Award from the local government of Hengqin New Area, Zhuhai City, China; CK Life Sciences (HKG:0775) has signed an agreement to acquire Australia-based Peaty Trading Group and its related assets for approximately A$31 million; Marubeni Corporation (TYO:8002) says that its subsidiary Marubeni Access is now providing international IP-VPN service, named VECTANT Global IP-VPN to Japanese companies' overseas subsidiaries; Toray Industries Inc. (TYO:3402) has restructured its research and development bases in Shanghai and Nantong, China.
2011/07/27 12:24 - Asian Activities Report for July 27, 2011 includes: South American Iron & Steel Corporation Limited (ASX:SAY) has amended its agreement to acquire an 11.25% interest in an exploration Concession in Weishan County, Yunnan, China; Rex Minerals Limited (ASX:RXM) has completed a conceptual study of its 100% owned Hillside Project in South Australia; Aquila Resources Limited (ASX:AQA) will resume normal shipments of coal from Isaac Plains Coal Mine; Regal Resources Limited (ASX:RER) has appointed Stanford University in California to conduct Phase Two Proof of Concept Testing of its UCTL technology; United Phosphorus Limited (BOM:512070) has acquired a 51% stake in DVA Agro Do Brasil.
2010/12/21 11:34 - China Bio-Agriculture Industry Summit 2011 will be convened in Shanghai China on February 24-25, 2011. It is committed to providing a comprehensive picture of policy support, market trends, multi-national cooperation in R&D and technical innovations and investment climate of the industry.
2010/02/25 13:30 - Asian markets mostly dropped on Wednesday. Resources shares across the region were hit by falling metals prices. Japan's Nikkei 225 fell 1.5 per cent, South Korea's Kospi shed 1.0 per cent and Hong Kong's Hang Seng Index lost 0.8 per cent. The markets also weighed down by U.S. consumer confidence and German business sentiment. But China's Shanghai Composite rebounded 1.3 per cent as monetary tightening worries eased.
2009/05/26 11:53 - Australian healthcare company Stirling Products Limited (ASX:STI) is pleased to announce another milestone in the expansion of the licensed (pending joint venture approval) botanical products to markets outside of Ukraine. Immunoxel (Dzherelo) has been granted approval in South Africa. This approval will allow immediate sales of the phytoconcentrate as an immune adjuvant for TB and HIV treatment.
2008/11/10 13:29 - Stirling Products (ASX:STI) advises shareholders that it has terminated its relationship with West Australian company Cocky Smart Pty Ltd for the exclusive global licensing rights to their novel insecticide compound originally isolated from cockatoo feathers.
2008/11/07 12:04 - Stirling Products (ASX:STI) advises shareholders that it has received notice that its patent application for "Methods of decreasing fat deposits and body weight in mammals and birds" has been granted in New Zealand. Patent applications have been filed in a number of different countries; this represents the first successful approval.
2008/10/01 12:12 - Stirling Products (ASX:STI) advises shareholders that it launched PetQuench(tm), the first of its companion animal products, at one of Canada's largest pet shows last weekend. PetQuench(tm) was released onto the Canadian market through Stirling Animal Health at the prestigious PIJAC National Industry Trade Show in Ontario, Canada.
2008/09/11 13:19 - Stirling Products (ASX:STI) advises shareholders that it has commenced a consolidation process that will result in a dedicated subsidiary for its global sales and marketing efforts. Stirling has over the last two years undergone a growth and acquisition phase with the establishment of the Danish joint venture Pulmovet in July 2006 (ASX: July 13, 2006), the acquisition of Progressive BioActives Inc.
2008/08/14 13:35 - Stirling Products (ASX:STI) advises shareholders that it has now completed the transaction to acquire worldwide licensing rights for the product PetQuench(tm). PetQuench(tm), fortified water for dogs and cats, is already on the market in North America and is expected to be launched in Australia by the end of Q1 2009.
2008/07/28 16:57 - Stirling Products (ASX:STI) wishes to advise shareholders that its patent application for "the treatment of heaves in horses" with R-salbutamol has now been granted in Australia. The company previously announced that the patent had also been approved in South Africa (ASX, October 10, 2006).
2008/07/15 12:28 - Stirling Products North America Inc (STI-NA)(ASX:STI) has presented results of a ground-breaking study into the Loma gill disease infection of farmed fish, especially salmon and trout, at the 2008 Annual Meeting of the American Fisheries Society (FHS-AFS). The results presented demonstrate the effectiveness of Stirling's proprietary beta glucan product, ProVale(tm), in inhibiting the impact of Loma salmonae, a costly and untreatable disease in farmed fish, especially Pacific salmon.
2008/06/16 11:30 - Stirling Products (ASX:STI) advises shareholders it has signed an agreement in principle with the private Western Australian company Cocky Smart Pty Ltd for the Australian and international rights to its novel parasiticide for the prevention of flies and ticks primarily with applications in livestock.
2008/06/13 12:25 - Stirling Products Limited (ASX:STI), an animal healthcare development and commercialization company, today announced that it is launching its presence into the companion animal healthcare market at the BIO2008 Annual Convention in San Diego, June 17-20, 2008.
2008/06/10 16:49 - Stirling Products (ASX: STI) advises that its wholly-owned North American subsidiary, Stirling Products North America Inc (STI-NA), has successfully completed product validation trials in shrimp with a leading global animal pharma company for applications for its proprietary immunobiotic ProVale(TM).
2008/06/04 15:09 - Stirling Products (ASX:STI) advises shareholders that it has signed a term sheet with Aquience, a Canadian company, for the exclusive rights to its companion animal product PetQuench(tm), which is already being sold and distributed in North America.
2008/05/30 12:14 - Stirling Products (ASX: STI) advises that its North American wholly-owned subsidiary Stirling Products North America Inc. (STI-NA), has signed a Collaboration and Supply Agreement for its lead product ProVale(tm), a highly purified beta glucan.
2008/05/28 13:21 - Stirling Products (ASX: STI) advises that its South African partner, Afgri Limited, has submitted the next stage in the regulatory process towards Act 36 approval.
2008/03/26 11:12 - Stirling Products (ASX: STI) advises that its North American wholly-owned subsidiary, Stirling Products North America Inc (STI-NA), has now signed a lease agreement to become the cornerstone tenant in Prince Edward Island's newest commercial BioScience Park facility. STI-NA has signed the lease agreement within the new state of the art two storey 50,000 square foot bio facility.
2008/03/18 12:18 - Stirling Products (ASX: STI) advises that its North American wholly-owned subsidiary, Stirling Products North America Inc. (SPNA), has offered terms and conditions to Distribution Claude Levesque Inc. (DCL) to sell and distribute Stirling's beta glucan product ProVale. Under the terms of the Memorandum of Understanding, both parties will have three months to finalize a formal agreement.
2008/03/10 09:44 - Stirling Products Limited (ASX: STI) advises shareholders that it has signed a Term Sheet and Letter of Understanding with the company Equine Healthcare Limited, based in the United Kingdom, for the first option to license, manufacture and distribute its patented 'early detection device' for respiratory disorders.
2008/03/06 11:38 - Stirling Products North America Inc (trading as Progressive BioActives Inc) and PEI Pork Plus Inc have signed an MOU which provides Stirling with the opportunity to become the exclusive sales and distribution partner for PEI Pork's Omega-3 Meat Enhancement Technology. The MOU covers all livestock applications including swine, poultry, lamb and cattle markets in Australia, New Zealand and various Asian Pacific regions.
2008/02/05 14:04 - Stirling Products Limited (ASX: STI) advises shareholders that its North American subsidiary (Stirling Products North America Inc. trading as Progressive BioActives Inc.), has signed a Term sheet with US-based aquaculture company Aqua Bounty Technologies (London stock exchange symbol ABTX) to begin trials of ProVale(tm) in the Chilean salmon market.
2008/01/30 12:25 - Stirling Products (ASX: STI) advises that it has received written notification of registration approval under the new Feeds Act classification for Yeast Cell Wall Beta Glucan products by the Canadian Food Inspection Agency (CFIA). The two products, ProVale Yeast Cell Wall for Livestock Feeds and ProVale Yeast Cell Wall Premix for Livestock Feeds are now recognized as containing an independently validated and minimum quantity of activated beta glucan from purified yeast cell wall material under the recently amended guidelines implemented by the CFIA.
2008/01/24 12:26 - Stirling Products (ASX: STI) advises that it has recently received information from its current Distribution partner in South Africa (Afgri Operations Pty Limited) that the MCC has approved the application for R-salbutamol to be included under Section 36 of the Stock Remedy Act. The approval means that Afgri, on behalf of Stirling Products, can now conduct the necessary trials for registration and commercialisation under this Act rather than the more stringent MCC process."
2008/01/10 12:13 - The Directors of Stirling Products Limited (ASX: STI) are pleased to announce that the Company has completed a private placement of 42,770,000 fully paid ordinary shares at $0.05 raising A$2,138,500 million. The placement of these shares was approved by Shareholders at the Company's Annual General Meeting held on 22 November, 2007.
2007/12/12 10:52 - Stirling Products (ASX: STI) advises that Stirling Products North America Incorporated (STI-NA) has completed discussions and signed a Material Transfer Agreement (MTA) with Pharmswell Co Ltd., based in Seoul, South Korea. The MTA covers the supply of the product ProVale(tm), from its Canadian facility.
2007/12/05 10:54 - Stirling Products (ASX: STI) advises that Stirling Products North America Incorporated (STI-NA) has completed the first phase of the manufacturing scale-up at its Charlottetown facility. The increase in production will satisfy future demands for its newly acquired product ProVale(tm), manufactured at the facility.
2007/11/20 12:48 - Stirling Products (ASX: STI) advises that, following an announcement last week by the Canadian retailer Co-op Atlantic and its partner the Natural Organic Food Group (NOFG) that they will commence selling Omega-3 enhanced pork products, Stirling Products North America (SPNA) expects increased distribution sales revenue from its Omega-3 premix supplied to the partnership. SPNA, based on Prince Edward Island, Canada, has the exclusive rights to distribute the Omega-3 premix which is currently manufactured to proprietary specifications by KenPal Inc., a leading Canadian supplier of custom premixes and nutritional supplements.
2007/11/12 12:48 - Stirling Products (ASX: STI) advises that it has successfully signed a Letter of Intent (LOI) and finalised a Term Sheet with a leading and progressive USA nutritional feed premix manufacturer and distributor.
2007/10/16 15:22 - Stirling Products Limited (ASX: STI) advises shareholders that studies recently conducted at the University of Western Australia have confirmed the superior biological potency of R-salbutamol over racemic salbutamol.
Ag Biotechnology